Evidence map›Paper›PMID 25271834›Full record

ArticlePloS one2014

Chloroquine is a zinc ionophore.

Jing Xue, Amanda Moyer, Bing Peng, Jinchang Wu, Bethany N Hannafon, Wei-Qun Ding

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04370782 (A Randomized Study Evaluating the Safety and Efficacy of Hydroxychloroquine and Zinc in Combination With Either Azithromycin or Doxycycline for the Treatment of COVID-19 in the Outpatient Setting), which is not on this map. Cited by 121 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04370782 phase4completednot on this mapstarted 2020, after this paper: background citation

A Randomized Study Evaluating the Safety and Efficacy of Hydroxychloroquine and Zinc in Combination With Either Azithromycin or Doxycycline for the Treatment of COVID-19 in the Outpatient Setting

TypeinterventionalSponsorSt. Francis Hospital, New YorkRan2020 to 2020Enrolled18ConditionsCOVID-19ArmsHydroxychloroquine, Azithromycin, Zinc Sulfate, Doxycycline
3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 1 synthesis or guideline pooled it, 238 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Chloroquine inhibits artificial oocyte activation induced by ethanol or SrThe Journal of reproduction and development · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Jing XueDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America; Department of Radio-Oncology, Nanjing Medical University Affiliated Suzhou Hospital, Suzhou, China.
Amanda MoyerDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America.
Bing PengDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America; Department of Pharmacology, School of Pharmacy, Xuzhou Medical College, Xuzhou, China.
Jinchang WuDepartment of Radio-Oncology, Nanjing Medical University Affiliated Suzhou Hospital, Suzhou, China.
Bethany N HannafonDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America.
Wei-Qun DingDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America.
University of Oklahoma Health Sciences Center · USNanjing Medical University · CN

Funding

Tracking and Evaluation CoreU54GM104938 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI PAUL G SPICER · 2013 to 2026
$68.2M
Proteomics CoreP20GM103447 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI DARRIN R. AKINS · 2012 to 2026
$60.2M
VACCINE-TARGETED IDENTIFICATION OF FITNESS DETERMINANTS IN THE HIV-1 ENVELOPEP20RR016478 · NCRR · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI LEWIS, SHARON A · 2001 to 2011
$35.8M
NCRR NIH HHS 3P20RR016478-09SNCRR NIH HHS P20 RR016478NIGMS NIH HHS U54 GM104938
6 · The paper itself

Abstract

Chloroquine is an established antimalarial agent that has been recently tested in clinical trials for its anticancer activity. The favorable effect of chloroquine appears to be due to its ability to sensitize cancerous cells to chemotherapy, radiation therapy, and induce apoptosis. The present study investigated the interaction of zinc ions with chloroquine in a human ovarian cancer cell line (A2780). Chloroquine enhanced zinc uptake by A2780 cells in a concentration-dependent manner, as assayed using a fluorescent zinc probe. This enhancement was attenuated by TPEN, a high affinity metal-binding compound, indicating the specificity of the zinc uptake. Furthermore, addition of copper or iron ions had no effect on chloroquine-induced zinc uptake. Fluorescent microscopic examination of intracellular zinc distribution demonstrated that free zinc ions are more concentrated in the lysosomes after addition of chloroquine, which is consistent with previous reports showing that chloroquine inhibits lysosome function. The combination of chloroquine with zinc enhanced chloroquine's cytotoxicity and induced apoptosis in A2780 cells. Thus chloroquine is a zinc ionophore, a property that may contribute to chloroquine's anticancer activity.

Indexed as

Cell LineCell Line, TumorChloroquineFemaleFluorescent DyesHumansZincChloroquineFluorescent DyesZinc

Identifiers

PMID25271834
PMCPMC4182877
OpenAlexW2087356499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.